Outcome After Reperfusion Therapies in Patients With Large Baseline Diffusion-Weighted Imaging Stroke Lesions: A THRACE Trial (Mechanical Thrombectomy After Intravenous Alteplase Versus Alteplase Alone After Stroke) Subgroup Analysis.
Fiche publication
Date publication
mars 2018
Journal
Stroke
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis
Tous les auteurs :
Gautheron V, Xie Y, Tisserand M, Raoult H, Soize S, Naggara O, Bourcier R, Richard S, Guillemin F, Bracard S, Oppenheim C
Lien Pubmed
Résumé
Stroke patients with large diffusion-weighted imaging (DWI) volumes are often excluded from reperfusion because of reckoned futility. In those with DWI >70 mL, included in the THRACE trial (Mechanical Thrombectomy After Intravenous Alteplase Versus Alteplase Alone After Stroke), we report the associations between baseline parameters and outcome.
Mots clés
Adolescent, Adult, Aged, Aged, 80 and over, Diffusion Magnetic Resonance Imaging, Female, Humans, Male, Middle Aged, Stroke, diagnostic imaging, Thrombectomy, methods, Tissue Plasminogen Activator, administration & dosage
Référence
Stroke. 2018 03;49(3):750-753